COMMUNIQUÉS West-GlobeNewswire

SuperSonic Imagine’s Aixplorer® Ultimate Highlighted at American Institute of Ultrasound in Medicine Meeting in New York

21/03/2018 - 12:00

Aix-en-Provence, France, March 21, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will highlight its premium [...]

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results

21/03/2018 - 12:00

BERKELEY HEIGHTS, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]

Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference

21/03/2018 - 12:00

CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, [...]

Bringing Generations Together Through Music

21/03/2018 - 12:00

DALLAS, March 21, 2018 (GLOBE NEWSWIRE) -- According to research, music and intergenerational interaction 1 can enhance cognitive abilities and quality of life in children 2 , parents, and seniors 3 . As part of its [...]

Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec To Manufacture Universal Donor Cell Therapies

21/03/2018 - 12:00

SEATTLE and PHILADELPHIA, March 21, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal donor cell therapies for patients with hematologic malignances and other critical diseases, and WuXi [...]

Nabriva Therapeutics Appoints Jennifer Schranz, M.D., as Chief Medical Officer

21/03/2018 - 12:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]

Capricor Therapeutics to Present at Upcoming Oppenheimer and Needham Healthcare Conferences

21/03/2018 - 12:00

LOS ANGELES, March 21, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced that it will participate in two upcoming investment banking conferences, Oppenheimer’s 28 th Annual Healthcare [...]

Recro Pharma to Present at the 17th Annual Needham Healthcare Conference

21/03/2018 - 12:00

MALVERN, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today [...]

Akari Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Clinical Progress

21/03/2018 - 12:00

Received Regulatory Clearance in Europe to Open First Clinical Trial Site for Phase III PNH Naïve Trial CAPSTONE, the Phase III Naïve PNH Trial Expected to Open in Q1 2018 Phase II PNH Trial Completed With Primary [...]

Fennec Pharmaceuticals Receives Fast Track Designation by FDA for PEDMARK

21/03/2018 - 11:30

RESEARCH TRIANGLE PARK, N.C., March 21, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration ( [...]

EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure

21/03/2018 - 11:01

Insurer Takes its Cue from Updated NCCN Guidelines, Which Recognizes HIFU as Salvage Treatment for Prostate Cancer Lyon, France, Austin, TX -- March 21, 2018 - EDAP TMS SA (Nasdaq: EDAP) today announced that CIGNA [...]

Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.

21/03/2018 - 11:00

RANCHO CUCAMONGA, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that on March 20, 2018, the United States Court for the District of Massachusetts (the “District [...]

PotNetwork Holding Inc. Leadership Appears on The Mick Bazsuly Show, Projects 60-70% Gains in Revenues for 2018

21/03/2018 - 11:00

FORT LAUDERDALE, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding Inc. (OTC Pink:POTN) On Tuesday the 20th of March in 2018, PotNetwork Holding Inc. CEO Dr. Richard Goulding and Senior [...]

RavenQuest Obtains OTCQB Listing Under Symbol “RVVQF”

21/03/2018 - 11:00

VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) is pleased to announce that OTC Markets Group Inc. has [...]

Amarin Announces First Middle East Approval for Vascepa®

21/03/2018 - 10:00

BEDMINSTER, N.J. and DUBLIN, Ireland, March 21, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Helsinn Group announces agreement to acquire worldwide rights to Valchlor/Ledaga, an approved and marketed alkylating agent for topical treatment of mycosis fungoides type cutaneous T-cell lymphoma

21/03/2018 - 09:00

Helsinn Group announces agreement to acquire worldwide rights to Valchlor ® /Ledaga ® - an approved and marketed alkylating agent for the topical treatment of mycosis fungoides- type cutaneous T- cell lymphoma, a rare [...]

Notice Convening the Annual General Meeting

21/03/2018 - 08:54

March 21, 2018 Announcement no. 6 Notice Convening the Annual General Meeting The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S: April 13, 2018, at 3.00 pm (CET), At the Company’s address [...]

Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics

21/03/2018 - 08:15

VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) ( “ Veritas ” or the “Company”) is pleased to announce the Company has completed the 100% [...]

DBV Technologies Announces Pricing of $150.0 million (€122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares

21/03/2018 - 08:01

Montrouge, France, March 21, 2018 DBV Technologies Announces Pricing of $150.0 million ( € 122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares DBV Technologies (the " [...]